4.
化疗联合热疗组与单独化疗组疗效与安全性比较的meta分析
Meta analysis of efficacy and safety for patients with NSCLC treated with Thermo-Chemotherapy and Chemotherapy alone
| Outcome | Included studies | TCT | CT | Heterogeneity | Statistical method | Result of meta-analysis | ||||||
| n | N | n | N | I2 | P | OR (95%CI) | P | |||||
| Improving rate of life quality | 8[3, 5-8, 10, 12, 14] | 184 | 250 | 108 | 250 | 0% | 0.96 | OR (M-H, Fixed, 95%CI) | 3.84 (2.61-5.64) | < 0.000, 01 | ||
| Myelosuppression | 6[3, 8, 9, 11, 13, 15] | 133 | 200 | 142 | 205 | 0% | 0.81 | OR (M-H, Fixed, 95%CI) | 0.88 (0.57-1.37) | 0.58 | ||
| Gastrointestinal reaction | 5[3, 8, 11, 13, 15] | 115 | 150 | 120 | 155 | 0% | 0.98 | OR (M-H, Fixed, 95%CI) | 0.98 (0.56-1.71) | 0.93 | ||
| Hepatic lesion | 3[3, 8, 11] | 21 | 101 | 20 | 103 | 0% | 0.83 | OR (M-H, Fixed, 95%CI) | 1.09 (0.54-2.19) | 0.82 | ||
| Renal lesion | 3[3, 8, 11] | 14 | 101 | 14 | 103 | 0% | 0.48 | OR (M-H, Fixed, 95%CI) | 1.02 (0.46-2.26) | 0.96 | ||
| Diarrhoea | 4[3, 8, 13, 15] | 30 | 119 | 26 | 122 | 0% | 0.88 | OR (M-H, Fixed, 95%CI) | 1.26 (0.69-2.31) | 0.45 | ||